Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Two publications considered of being not assignable were available dealing with acute toxicity of cyclooctanone (Caujolle and Caujolle, 1965; Caujolle et al. 1962). Based on limited reliability of the studies, cyclooctanone does not require classification for acute toxicity.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Remarks:
publication
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment
Remarks:
only short report
Qualifier:
no guideline available
Principles of method if other than guideline:
Rats and mice were exposed to cycloalkanones. LD50 values in mM/kg following intraperitoneal injection into mice and rats and LD50 values in mM/kg following peroral exposure in mice were obtained.
GLP compliance:
not specified
Species:
other: mouse and rat
Strain:
other: Swiss mice, Wistar rats
Sex:
male/female
Route of administration:
other: oral via gavage, i.p. via injection
Vehicle:
other: pure or in olive oil
Control animals:
not specified
Details on study design:
Wistar rats of both sexes (190±10g) were exposed to cyclooctanopne in neutralised olive oil. Oral application of pure or oily soultion of cyclooctanone was performed.
Sex:
male/female
Dose descriptor:
LD50
Effect level:
10.03 other: mM/kg
Based on:
test mat.
Clinical signs:
other: dizziness, prostration, reduced muscle tone, pain sensitivity, accelerated breathing
Gross pathology:
no specific pattern but seen tubulointerstitial nephritis, degenerative lesions in liver and rarely pancreatic necrosis

Table: LD50 values for cyclooctanone

Species

Route

LD50

mouse

i.p.

5.8 mM/kg equals ca. 0.74 g/kg

mouse

oral

10.03 mM/kg  equals ca. 1.31 g/kg

rat

i.p

5.16 mM/kg  equals ca. 0.66 g/kg

Interpretation of results:
study cannot be used for classification
Remarks:
reliability 4
Conclusions:
Based on limited reliability of the study, cyclooctanone does not require classification for acute toxicity.
Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
1 310 mg/kg bw
Quality of whole database:
limited reliablity due to publication with insufficient documentation

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Caujolle and Caujolle (1965) and Caujolle et al. (1962) reported LD50 values of 0.74 g/kg in mice and 0.66 g/kg in rat following i.p. application of cyclooctanone.

Justification for classification or non-classification

Based on limited reliability of the published data on acute toxicity (insufficient documentation), cyclooctanone does not require classification for acute toxicity.